Holen Sie sich die Stockscreener-App
22.80
6.29%
-1.53
Handel nachbörslich:
22.80
Schlusskurs vom Vortag:
$24.33
Offen:
$24.55
24-Stunden-Volumen:
627.48K
Relative Volume:
1.02
Marktkapitalisierung:
$1.02B
Einnahmen:
$681.75M
Nettoeinkommen (Verlust:
$70.47M
KGV:
15.72
EPS:
1.45
Netto-Cashflow:
$173.19M
1W Leistung:
-3.47%
1M Leistung:
-0.96%
6M Leistung:
-14.77%
1J Leistung:
+33.88%
1-Tages-Spanne:
$22.77
$24.95
1-Wochen-Bereich:
$22.77
$24.95
52-Wochen-Spanne:
$16.29
$27.98
Pacira Biosciences Inc Stock (PCRX) Company Profile
Firmenname
Pacira Biosciences Inc
Sektor
Telefon
650-242-8052
Adresse
2000 SIERRA POINT PARKWAY, BRISBANE, NJ
Vergleichen Sie PCRX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PCRX
Pacira Biosciences Inc
|
22.80 | 1.05B | 681.75M | 70.47M | 173.19M | 1.45 |
|
ZTS
Zoetis Inc
|
115.89 | 51.60B | 9.40B | 2.65B | 2.24B | 5.935 |
|
TAK
Takeda Pharmaceutical Co Adr
|
14.06 | 44.51B | 29.63B | 260.53M | 5.51B | 0.0788 |
|
HLN
Haleon Plc Adr
|
9.60 | 42.35B | 14.26B | 1.98B | 2.47B | 0.4327 |
|
TEVA
Teva Pharmaceutical Industries Ltd Adr
|
24.28 | 28.04B | 16.70B | -157.13M | 1.19B | -0.1446 |
|
UTHR
United Therapeutics Corp
|
474.72 | 20.52B | 3.08B | 1.24B | 1.07B | 25.61 |
Pacira Biosciences Inc Stock (PCRX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-11-17 | Eingeleitet | H.C. Wainwright | Buy |
| 2025-07-25 | Hochstufung | Truist | Hold → Buy |
| 2025-01-30 | Hochstufung | Truist | Sell → Hold |
| 2024-08-13 | Herabstufung | Truist | Buy → Sell |
| 2024-08-12 | Herabstufung | JP Morgan | Overweight → Underweight |
| 2024-08-12 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2024-08-12 | Herabstufung | RBC Capital Mkts | Outperform → Sector Perform |
| 2024-08-12 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-07-03 | Herabstufung | Barclays | Overweight → Equal Weight |
| 2024-03-07 | Fortgesetzt | JP Morgan | Overweight |
| 2023-12-20 | Eingeleitet | Raymond James | Outperform |
| 2023-08-03 | Hochstufung | TD Cowen | Market Perform → Outperform |
| 2023-01-31 | Fortgesetzt | Wedbush | Outperform |
| 2022-10-21 | Fortgesetzt | Jefferies | Buy |
| 2022-01-03 | Fortgesetzt | JP Morgan | Overweight |
| 2021-07-26 | Hochstufung | JP Morgan | Neutral → Overweight |
| 2021-04-21 | Fortgesetzt | JP Morgan | Neutral |
| 2021-04-09 | Eingeleitet | Berenberg | Buy |
| 2021-04-07 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2021-02-11 | Herabstufung | Northland Capital | Outperform → Market Perform |
| 2021-01-21 | Herabstufung | SVB Leerink | Outperform → Mkt Perform |
| 2020-09-21 | Hochstufung | Northland Capital | Market Perform → Outperform |
| 2020-07-06 | Bestätigt | Needham | Buy |
| 2020-05-27 | Eingeleitet | Guggenheim | Neutral |
| 2020-04-07 | Eingeleitet | Northland Capital | Outperform |
| 2020-03-20 | Hochstufung | SVB Leerink | Mkt Perform → Outperform |
| 2020-02-24 | Bestätigt | H.C. Wainwright | Buy |
| 2020-01-24 | Eingeleitet | SunTrust | Buy |
| 2020-01-23 | Eingeleitet | SunTrust | Buy |
| 2019-11-06 | Eingeleitet | BTIG Research | Buy |
| 2019-06-11 | Eingeleitet | Barclays | Overweight |
| 2019-05-06 | Hochstufung | Mizuho | Underperform → Neutral |
| 2019-05-02 | Hochstufung | Stifel | Sell → Hold |
| 2019-02-01 | Herabstufung | Mizuho | Neutral → Underperform |
| 2018-08-06 | Herabstufung | BofA/Merrill | Buy → Neutral |
| 2018-04-09 | Bestätigt | H.C. Wainwright | Buy |
| 2018-03-21 | Bestätigt | Mizuho | Neutral |
| 2018-02-16 | Herabstufung | Needham | Buy → Hold |
| 2018-01-19 | Eingeleitet | Seaport Global Securities | Buy |
| 2018-01-04 | Bestätigt | Canaccord Genuity | Buy |
| 2018-01-03 | Eingeleitet | Leerink Partners | Mkt Perform |
Alle ansehen
Pacira Biosciences Inc Aktie (PCRX) Neueste Nachrichten
Is Pacira BioSciences Inc. (82P) stock attractive for dividend growth2025 Volatility Report & Fast Exit and Entry Trade Guides - newser.com
Is Pacira BioSciences Inc. (82P) stock a top pick for value investorsMarket Sentiment Report & Weekly Sector Rotation Insights - newser.com
Will Pacira BioSciences Inc. stock rally after Fed decisionsJuly 2025 Retail & AI Forecasted Entry and Exit Points - newser.com
What macro factors could drive Pacira BioSciences Inc. (82P) stock higherBond Market & Comprehensive Market Scan Insights - newser.com
How Pacira BioSciences Inc. (82P) stock moves in volatile trading sessions2025 Short Interest & Fast Gaining Stock Reports - newser.com
Will Pacira BioSciences Inc. (82P) stock beat Nasdaq index returnsWeekly Trend Report & Daily Chart Pattern Signals - newser.com
How Pacira BioSciences Inc. stock valuations compare to rivalsTrade Exit Report & Advanced Swing Trade Entry Plans - newser.com
What is the fair value estimate for Pacira BioSciences Inc. (82P) stock in 2025Weekly Trade Analysis & Technical Buy Zone Confirmations - newser.com
Why Pacira BioSciences Inc. (82P) stock attracts wealthy investorsEarnings Growth Summary & Fast Gain Stock Trading Tips - newser.com
Bronstein, Gewirtz & Grossman, LLC Encourages Pacira BioSciences, Inc. (PCRX) Investors to Inquire about Securities Investigation - ACCESS Newswire
Insider Sell: Jonathan Slonin Sells Shares of Pacira BioSciences Inc (PCRX) - GuruFocus
Real time social sentiment graph for Pacira BioSciences Inc.Weekly Trade Summary & Community Consensus Picks - newser.com
Will Pacira BioSciences Inc. (82P) stock deliver compounding returnsBull Run & Weekly Top Gainers Trade List - newser.com
Should I hold or sell Pacira BioSciences Inc. stock in 20252025 Performance Recap & Real-Time Buy Signal Notifications - newser.com
How Pacira BioSciences Inc. (82P) stock valuation compares with sector2025 Volume Leaders & AI Forecasted Entry and Exit Points - newser.com
Is Pacira BioSciences Inc. stock poised for growthTrade Volume Summary & Entry Point Confirmation Signals - newser.com
Will Pacira BioSciences Inc. stock keep outperforming rivalsWeekly Market Summary & Real-Time Buy Signal Alerts - newser.com
Will Pacira BioSciences Inc. (82P) stock benefit from mergers2025 Sector Review & Daily Chart Pattern Signal Reports - newser.com
Using data tools to time your Pacira BioSciences Inc. exitJuly 2025 Chart Watch & Daily Market Momentum Tracking - newser.com
(PCRX) Risk Channels and Responsive Allocation - news.stocktradersdaily.com
How to use a screener to detect Pacira BioSciences Inc. breakoutsFed Meeting & Safe Capital Investment Plans - newser.com
What analysts say about Pacira BioSciences Inc 82P stockPrice-to-Book Ratio Updates & Free Real-Time Trading Signals - earlytimes.in
Finanzdaten der Pacira Biosciences Inc-Aktie (PCRX)
Umsatz
Nettogewinn
Free Cashflow
ENV
6.17%
0.67%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):